Skip to content
Monday, November 24, 2025
SMS Alerts

  • YouTube
  • Instagram
  • Twitter
  • Telegram
  • Home đźź§
  • Instagram
  • Telegram
  • Text Message Alerts📱
  • Twitter / X
  • YouTube▶️
  • Contact Us

Tag: Johnson & Johnson

  • Home
  • Johnson & Johnson
Johnson & Johnson (NYSE: JNJ) Releases Q1 Fiscal 2025 Results: Is This Dividend Stock Still a Buy Amid Tariff Fears?
  • Drug Manufacturers
  • Healthcare
  • Red Hot Stocks

Johnson & Johnson (NYSE: JNJ) Releases Q1 Fiscal 2025 Results: Is This Dividend Stock Still a Buy Amid Tariff Fears?

  • Lawrence Bolt
  • April 15, 2025
  • 0

Johnson & Johnson (NYSE: $JNJ), a major multinational that produces medical devices and pharmaceuticals, released its first-quarter fiscal 2025 results on Tuesday, April 15, 2025, […]

Johnson & Johnson (NYSE: JNJ) Posts Earnings Beat In Q4 Fiscal 2024 Results: Here is Why The Stock Dipped
  • Drug Manufacturers
  • Healthcare
  • Red Hot Stocks

Johnson & Johnson (NYSE: JNJ) Posts Earnings Beat In Q4 Fiscal 2024 Results: Here is Why The Stock Dipped

  • Lawrence Bolt
  • January 23, 2025
  • 0

Johnson & Johnson (NYSE: $JNJ) stock remained flat during the Wednesday, January 22, 2025, trading session after exceeding analysts’ expectations in its Q4 results. Johnson […]

Johnson & Johnson (NYSE: $JNJ) Falls 2%+ on Tuesday After Mixed Q1 Results and Narrowed Guidance 
  • Drug Manufacturers
  • Healthcare
  • Red Hot Stocks

Johnson & Johnson (NYSE: $JNJ) Falls 2%+ on Tuesday After Mixed Q1 Results and Narrowed Guidance 

  • Lawrence Bolt
  • April 17, 2024
  • 0

Johnson & Johnson (NYSE: $JNJ) is an American multinational pharmaceutical and medical technologies corporation headquartered in New Brunswick, New Jersey, founded by three brothers in […]

Rallybio (NASDAQ: $RLYB) Skyrockets 82%+ on Thursday After Announcing Johnson & Johnson Partnership
  • Biotech
  • Healthcare
  • Red Hot Stocks

Rallybio (NASDAQ: $RLYB) Skyrockets 82%+ on Thursday After Announcing Johnson & Johnson Partnership

  • Lawrence Bolt
  • April 11, 2024
  • 0

Rallybio (NASDAQ: $RLYB) is a clinical-stage biotech firm working on life-changing therapies for patients with severe and rare diseases. Headquartered in Connecticut, the company’s portfolio […]

Subscribe for the Latest News & Breakout Alerts:
*By Clicking 'Subscribe Now', You Hereby Agree That You Had Read, Understand, & Are In Agreement To All Terms & Conditions In Our Disclaimer & Privacy Policy.
Copyright © 2025 | DEXWireNews | PR News Videos | InteractiveApps